{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:30:21Z","timestamp":1790487021645,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005155","name":"Azrieli Foundation","doi-asserted-by":"publisher","award":["Private Donation"],"award-info":[{"award-number":["Private Donation"]}],"id":[{"id":"10.13039\/501100005155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fragile X premutation (Amplification of CGG number 55\u2013200) is associated with increased risk for fragile X-Associated Premature Ovarian Insufficiency (FXPOI) in females and fragile X-associated tremor\/ataxia syndrome (FXTAS) predominantly in males. Recently, it has been shown that CGG repeats trigger repeat associated non-AUG initiated translation (RAN) of a cryptic polyglycine-containing protein, FMRpolyG. This protein accumulates in ubiquitin-positive inclusions in neuronal brain cells of FXTAS patients and may lead to protein-mediated neurodegeneration. FMRpolyG inclusions were also found in ovary stromal cells of a FXPOI patient. The role of FMRpolyG expression has not been thoroughly examined in folliculogenesis related cells. The main goal of this study is to evaluate whether FMRpolyG accumulates in mural granulosa cells of FMR1 premutation carriers. Following FMRpolyG detection, we aim to examine premutation transfected COV434 as a suitable model used to identify RAN translation functions in FXPOI pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>FMRpolyG and ubiquitin immunostained mural granulosa cells from six FMR1 premutation carriers demonstrated FMRpolyG aggregates. However, co-localization of FMRpolyG and ubiquitin appeared to vary within the FMR1 premutation carriers\u2019 group as three exhibited partial ubiquitin and FMRpolyG double staining and three premutation carriers demonstrated FMRpolyG single staining. None of the granulosa cells from the five control women expressed FMRpolyG. Additionally, human ovarian granulosa tumor, COV434, were transfected with two plasmids; both expressing 99CGG repeats but only one enables FMRpolyG expression. Like in granulosa cells from FMR1 premutation carriers, FMRpolyG aggregates were found only in COV434 transfected with expended CGG repeats and the ability to express FMRpolyG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Corresponding with previous studies in FXTAS, we demonstrated accumulation of FMRpolyG in mural granulosa cells of FMR1 premutation carriers. We also suggest that following further investigation, the premutation transfected COV434 might be an appropriate model for RAN translation studies. Detecting FMRpolyG accumulation in folliculogenesis related cells supports previous observations and imply a possible common protein-mediated toxic mechanism for both FXPOI and FXTAS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-020-00623-w","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T09:02:49Z","timestamp":1582707769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["FMRpolyG accumulates in FMR1 premutation granulosa cells"],"prefix":"10.1186","volume":"13","author":[{"given":"M.","family":"Friedman-Gohas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Elizur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Dratviman-Storobinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Raanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Orvieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7242-0061","authenticated-orcid":false,"given":"Y.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"key":"623_CR1","volume-title":"Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes. Curr Opin Genet Dev","author":"B Bardoni","year":"2002","unstructured":"Bardoni B, Mandel J-L. Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes. Curr Opin Genet Dev . 2002 1 [cited 2018 Dec 9];12(3):284\u201393. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0959437X02003003?via%3Dihub"},{"issue":"5","key":"623_CR2","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/humrep\/13.5.1184","volume":"13","author":"GS Conway","year":"1998","unstructured":"Conway GS, Payne NN, Webb J, Murray A, Jacobs PA. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod. 1998;13(5):1184\u20137 [cited 2018 Dec 9]Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9647544.","journal-title":"Hum Reprod"},{"issue":"3","key":"623_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2006.09.004","volume":"87","author":"MD Wittenberger","year":"2007","unstructured":"Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, et al. The FMR1 premutation and reproduction. Fertil Steril. 2007;87(3):456\u201365 [cited 2018 Dec 9] Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028206040258.","journal-title":"Fertil Steril"},{"key":"623_CR4","volume-title":"Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve","author":"N Gleicher","year":"2009","unstructured":"Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve, vol. 19; 2009. [cited 2020 Jan 4]. Available from: www.rbmonline.com\/Article\/3871"},{"issue":"1","key":"623_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1212\/WNL.57.1.127","volume":"57","author":"RJ Hagerman","year":"2001","unstructured":"Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001;57(1):127\u201330 [cited 2018 Feb 8]Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11445641.","journal-title":"Neurology"},{"issue":"14","key":"623_CR6","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/mds.21493","volume":"22","author":"E Berry-Kravis","year":"2007","unstructured":"Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, Gane LW, et al. Fragile X-associated tremor\/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord. 2007;22(14):2018\u201330.","journal-title":"Mov Disord"},{"issue":"4","key":"623_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B","volume":"83","author":"DJ Allingham-Hawkins","year":"1999","unstructured":"Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJA, Yang KT, Lee C, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the international collaborative POF in fragile X study - preliminary data. Am J Med Genet. 1999;83(4):322\u20135.","journal-title":"Am J Med Genet"},{"issue":"4","key":"623_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.ejhg.5200451","volume":"8","author":"A Murray","year":"2000","unstructured":"Murray A, Ennis S, MacSwiney F, Webb J, Morton NE. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet. 2000;8(4):247\u201352.[cited 2018 Dec 29] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10854106.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"623_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.fertnstert.2008.07.007","volume":"92","author":"I Streuli","year":"2009","unstructured":"Streuli I, Fraisse T, Ibecheole V, Moix I, Morris MA, de Ziegler D. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil Steril. 2009;92(2):464\u201370 [cited 2018 Feb 8] Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028208014581.","journal-title":"Fertil Steril"},{"key":"623_CR10","doi-asserted-by":"crossref","unstructured":"Pal L, Torrealday S, Kodaman P. Premature Ovarian Insufficiency - an update on recent advances in understanding and management, vol. 6: F1000Research. Faculty of 1000 Ltd; 2017. [cited 2019 Nov 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5710309\/","DOI":"10.12688\/f1000research.11948.1"},{"issue":"2","key":"623_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/humrep\/12.2.241","volume":"12","author":"J Farhi","year":"1997","unstructured":"Farhi J, Homburg R, Ferber A, Orvieto R, Ben Rafael Z. Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre- empting the rise in basal follicle stimulating hormone levels. Hum Reprod. 1997;12(2):241\u20133 [cited 2019 Dec 19] Available from: https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/12.2.241.","journal-title":"Hum Reprod"},{"issue":"6","key":"623_CR12","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1210\/jcem-67-6-1190","volume":"67","author":"IT CAMERON","year":"1988","unstructured":"CAMERON IT, O\u2019SHEA FC, ROLLAND JM, HUGHES EG, DE KRETSERDM, DL HEALY. Occult Ovarian Failure: A Syndrome of Infertility, Regular Menses, and Elevated Follicle-Stimulating Hormone Concentrations. J Clin Endocrinol Metab. 1988;67(6):1190\u20134 [cited 2019 Dec 19]. Available from: https:\/\/academic.oup.com\/jcem\/article-lookup\/doi\/10.1210\/jcem-67-6-1190.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"623_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/oxfordjournals.humrep.a138490","volume":"9","author":"NA Ahmed Ebbiary","year":"1994","unstructured":"Ahmed Ebbiary NA, Lenton EA, Salt C, Ward AM, Cooke ID. The significance of elevated basal follicle stimulating hormone in regularly menstruating infertile women. Hum Reprod. 1994;9(2):245\u201352 Feb [cited 2019 Dec 19]Available from: https:\/\/academic.oup.com\/humrep\/article\/647880\/The.","journal-title":"Hum Reprod"},{"issue":"5","key":"623_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00439-004-1086-x","volume":"114","author":"W He","year":"2004","unstructured":"He W, Yadav-Shah M, Sherman SL, Allen EG. A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum Genet. 2004;114(5):439\u201347.[cited 2018 Feb 8] Available from: http:\/\/link.springer.com\/10.1007\/s00439-004-1086-x.","journal-title":"Hum Genet"},{"issue":"1","key":"623_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1866-1955-6-23","volume":"6","author":"C Sellier","year":"2014","unstructured":"Sellier C, Usdin K, Pastori C, Peschansky VJ, Tassone F, Charlet-Berguerand N. The multiple molecular facets of fragile X-associated tremor\/ataxia syndrome. J Neurodev Disord. 2014;6(1):23 [cited 2018 Dec 9] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25161746.","journal-title":"J Neurodev Disord"},{"issue":"2","key":"623_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.neuron.2016.12.016","volume":"93","author":"C Sellier","year":"2017","unstructured":"Sellier C, Buijsen RAM, He F, Natla S, Jung L, Tropel P, et al. Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia Syndrome. Neuron. 2017;93(2):331\u201347.[cited 2018 Feb 8] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28065649.","journal-title":"Neuron"},{"issue":"7","key":"623_CR17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/hmg\/11.7.805","volume":"11","author":"M Fardaei","year":"2002","unstructured":"Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS, et al. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet. 2002;11(7):805\u201314.[cited 2018 Feb 8] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11929853.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"623_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.molcel.2014.08.027","volume":"56","author":"R Batra","year":"2014","unstructured":"Batra R, Charizanis K, Manchanda M, Mohan A, Li M, Finn DJ, et al. Loss of MBNL Leads to Disruption of Developmentally Regulated Alternative Polyadenylation in RNA-Mediated Disease. Mol Cell. 2014;56(2):311\u201322 [cited 2018 Feb 8] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25263597.","journal-title":"Mol Cell"},{"issue":"3","key":"623_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ncl.2014.04.011","volume":"32","author":"CA Thornton","year":"2014","unstructured":"Thornton CA. M y o t o n i c D y s t ro p h y. Neurol Clin NA. 2014;32(3):705\u201319. [Cited 2019 Nov 4] Available from. https:\/\/doi.org\/10.1016\/j.ncl.2014.04.011.","journal-title":"Neurol Clin NA"},{"key":"623_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fncel.2017.00128","volume":"11","author":"HE Kong","year":"2017","unstructured":"Kong HE, Zhao J, Xu S, Jin P, Jin Y. Fragile X-Associated Tremor\/Ataxia Syndrome: From Molecular Pathogenesis to Development of Therapeutics. Front Cell Neurosci. 2017;11:128 [cited 2018 Jan 3] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28529475.","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"623_CR21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.neuron.2007.07.020","volume":"55","author":"P Jin","year":"2007","unstructured":"Jin P, Duan R, Qurashi A, Qin Y, Tian D, Rosser TC, et al. Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor\/ataxia syndrome. Neuron. 2007;55(4):556\u201364 [cited 2018 Jan 15] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17698009.","journal-title":"Neuron"},{"issue":"1","key":"623_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-013-1138-1","volume":"126","author":"Paul Hagerman","year":"2013","unstructured":"Hagerman P. fragile X-associated tremor\/ataxia syndrome (FXTAS): Pathology and mechanisms. Acta Neuropathologica. 2013;126:1\u201319. Available from https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3904666\/.","journal-title":"Acta Neuropathologica"},{"issue":"4","key":"623_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.neuron.2007.07.021","volume":"55","author":"OA Sofola","year":"2007","unstructured":"Sofola OA, Jin P, Qin Y, Duan R, Liu H, de Haro M, et al. RNA-binding proteins hnRNP A2\/B1 and CUGBP1 suppress fragile X CGG Premutation repeat-induced Neurodegeneration in a Drosophila model of FXTAS. Neuron. 2007;55(4):565\u201371.","journal-title":"Neuron."},{"issue":"3","key":"623_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","volume":"78","author":"Peter\u00a0K. Todd","year":"2013","unstructured":"Todd PK, Oh SY, Krans A, He F, Sellier C, Frazer M, et al. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron [Internet]. 2013 ;78(3):440\u2013455. [cited 2018 Jun 15]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23602499.","journal-title":"Neuron"},{"issue":"1","key":"623_CR25","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/s41467-017-02200-0","volume":"8","author":"KM Green","year":"2017","unstructured":"Green KM, Glineburg MR, Kearse MG, Flores BN, Linsalata AE, Fedak SJ, et al. RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response. Nat Commun. 2017;8(1):2005.[cited 2018 Jan 3] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29222490.","journal-title":"Nat Commun"},{"issue":"1","key":"623_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/humrep\/dev280","volume":"31","author":"RAM Buijsen","year":"2016","unstructured":"Buijsen RAM, Visser JA, Kramer P, Severijnen EAWFM, Gearing M, Charlet-Berguerand N, et al. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency. Hum Reprod. 2016;31(1):158\u201368 [cited 2018 Nov 5]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26537920.","journal-title":"Hum Reprod"},{"issue":"5","key":"623_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/rep.0.1240601","volume":"124","author":"A. Durlinger","year":"2002","unstructured":"Durlinger ALL, Visser JA, APN T. Regulation of ovarian function: the role of anti-M\u00fcllerian hormone. Reproduction. 2002;(5):124, 601\u20139 [cited 2019 Jul 2] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12416998.","journal-title":"Reproduction"},{"issue":"3","key":"623_CR28","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","volume":"78","author":"PK Todd","year":"2013","unstructured":"Todd PK, Oh SY, Krans A, He F, Sellier C, Frazer M, et al. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron. 2013;78(3):440\u201355 [cited 2018 Dec 9]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23602499.","journal-title":"Neuron"},{"issue":"4","key":"623_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1530\/REP-12-0305","volume":"145","author":"I Ferder","year":"2013","unstructured":"Ferder I, Parborell F, Sundblad V, Chiauzzi V, G\u00f3mez K, Charreau EH, et al. Expression of fragile X mental retardation protein and Fmr1 mRNA during folliculogenesis in the rat. Reproduction. 2013;145(4):335\u201343.[cited 2018 Feb 22] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23401597.","journal-title":"Reproduction"},{"issue":"7429","key":"623_CR30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature11737","volume":"492","author":"M Ascano","year":"2012","unstructured":"Ascano M, Mukherjee N, Bandaru P, Miller JB, Nusbaum JD, Corcoran DL, et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature. 2012;492(7429):382\u20136 [cited 2018 Jun 4]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23235829.","journal-title":"Nature"},{"issue":"7","key":"623_CR31","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/emboj.2010.21","volume":"29","author":"C Sellier","year":"2010","unstructured":"Sellier C, Rau F, Liu Y, Tassone F, Hukema RK, Gattoni R, et al. Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J. 2010;29(7):1248\u201361 [cited 2018 Feb 8]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20186122.","journal-title":"EMBO J"},{"key":"623_CR32","doi-asserted-by":"crossref","unstructured":"Elizur SE, Lebovitz O, Derech-Haim S, Dratviman-Storobinsky O, Feldman B, Dor J, et al. Elevated Levels of FMR1 mRNA in Granulosa Cells Are Associated with Low Ovarian Reserve in FMR1 Premutation Carriers. Bardoni B, editor. PLoS One . 2014 ;9(8):e105121. [cited 2020 Jan 4]. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0105121","DOI":"10.1371\/journal.pone.0105121"},{"issue":"1","key":"623_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1073\/pnas.1013343108","volume":"108","author":"T Zu","year":"2011","unstructured":"Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, et al. Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci U S A. 2011;108(1):260\u20135 [cited 2018 Feb 8]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21173221.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"623_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s40478-014-0162-2","volume":"2","author":"RA Buijsen","year":"2014","unstructured":"Buijsen RA, Sellier C, Severijnen L-AW, Oulad-Abdelghani M, Verhagen RF, Berman RF, et al. FMRpolyG-positive inclusions in CNS and non-CNS organs of a fragile X premutation carrier with fragile X-associated tremor\/ataxia syndrome. Acta Neuropathol Commun. 2014;2(1):162 [cited 2018 Feb 8]. Available from: http:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-014-0162-2.","journal-title":"Acta Neuropathol Commun"},{"key":"623_CR35","first-page":"3528","volume-title":"Extensive translation of small Open Reading Frames revealed by Poly-Ribo-Seq","author":"JL Aspden","year":"2014","unstructured":"Aspden JL, Chen Eyre-Walker Y, Phillips RJ, Amin U, Ali Mumtaz MS, Brocard M, et al. Extensive translation of small Open Reading Frames revealed by Poly-Ribo-Seq, vol. 3; 2014. p. 3528. [cited 2020 Jan 4];Available from: https:\/\/elifesciences.org\/articles\/03528"},{"issue":"3","key":"623_CR36","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","volume":"78","author":"PK Todd","year":"2013","unstructured":"Todd PK, Oh SY, Krans A, He F, Sellier C, Frazer M, et al. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron. 2013;78(3):440\u201355.[cited 2018 Feb 8] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23602499.","journal-title":"Neuron"},{"key":"623_CR37","volume-title":"Proteasome-mediated protein degradation resets the cell division cycle and triggers ESCRT-III-mediated cytokinesis in an archaeon","author":"G Tarrason Risa","year":"2019","unstructured":"Tarrason Risa G, Hurtig F, Bray S, Hafner AE, Harker-Kirschneck L, Faull P, et al. Proteasome-mediated protein degradation resets the cell division cycle and triggers ESCRT-III-mediated cytokinesis in an archaeon. 2019;"},{"issue":"24","key":"623_CR38","first-page":"6677","volume":"51","author":"H Kanayama","year":"1991","unstructured":"Kanayama H, Tanaka K, Aki M, Kagawa S, Miyaji H, Satoh M, et al. Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells. Cancer Res. 1991;51(24):6677\u201385 [cited 2020 Jan 4] Available from: https:\/\/cancerres.aacrjournals.org\/content\/51\/24\/6677.full-text.pdf.","journal-title":"Cancer Res"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00623-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-020-00623-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00623-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T19:23:55Z","timestamp":1614194635000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-020-00623-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["623"],"URL":"https:\/\/doi.org\/10.1186\/s13048-020-00623-w","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,26]]},"assertion":[{"value":"26 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Ethical Review Board of Sheba Medical Center, Israel. All patients that were included in this study signed a written informed consent. Helsinki no. 8707\u201311-SMC and 6140\u201319-SMC.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}